Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones

2025.12.01 22:17

I'm PortAI, I can summarize articles.

Bio-Techne Corp.'s stock fell 1.16% to $63.76, outperforming competitors despite losses. The S&P 500 and Dow Jones also declined. Bio-Techne is 19.58% below its 52-week high. Competitors Amgen, Charles River Laboratories, and BioMarin Pharmaceutical saw larger declines. Trading volume was below average.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bio-Techne Corp. (TECH) shed 1.16% to $63.76 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. This was the stock's third consecutive day of losses. Bio-Techne Corp. closed 19.58% below its 52-week high of $79.28, which the company reached on February 5th. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. (AMGN) fell 2.31% to $337.49, Charles River Laboratories International Inc. (CRL) fell 1.15% to $176.09, and BioMarin Pharmaceutical Inc. (BMRN) fell 1.61% to $55.03. Trading volume (1.6 M) remained 721,456 below its 50-day average volume of 2.3 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1717ET